It is well established that PPARα is a central regulator for hepatic glucose and lipid metabolism as well as the development of lipid disorders including hepatic steatosis and NAFLD [24–29]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.